Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Loperamide hydrochloride
IMED Healthcare Ltd.
A07DA; A07DA03
Loperamide hydrochloride
Orodispersible tablet
Antipropulsives; loperamide
2023-07-07
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IMODIUM ® INSTANTS 2 MG ORODISPERSIBLE TABLETS loperamide hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. This medicine is available without prescription and is used to treat sudden short-lived (acute) attacks of diarrhoea in adults and children aged 12 years and over. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4 ▶ . - You must talk to a doctor if you do not feel better or if you feel worse after 24 hours. WHAT IS IN THIS LEAFLET 1. What IMODIUM ® Instants is and what it is used for 2. What you need to know before you take IMODIUM ® Instants 3. How to take IMODIUM ® Instants 4. Possible side effects 5. How to store IMODIUM ® Instants 6. Contents of the pack and other information 1. WHAT IMODIUM ® INSTANTS IS AND WHAT IT IS USED FOR IMODIUM ® Instants is a medicine which is used to treat sudden short-lived (acute) attacks of diarrhoea in adults and children aged 12 years and over. The tablets contain loperamide hydrochloride which helps reduce diarrhoea by slowing down an overactive bowel, which helps the body to absorb water and salts from the bowel. IMODIUM ® Instants should be used in conjunction with oral rehydration therapy which replace fluids and salts lost during diarrhoea. You must talk to a doctor if you do not feel better or if you feel worse after 24 hours in case of acute diarrhoea. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE IMODIUM ® INSTANTS This medicine is suitable for most people, but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist. DO NOT TAKE IMODIUM ® INSTANTS… If you are allergic to loperamide or an Read the complete document
Health Products Regulatory Authority 07 July 2023 CRN00DFR7 Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Imodium Instants 2 mg Orodispersible Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Loperamide hydrochloride 2 mg per tablet. Excipient with known effect – Each tablet contains Aspartame (E951) and it contains Mint flavour which contains benzyl alcohol. The Mint flavouring contains traces of Sulphites. The Mint flavouring also contains glucose. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Orodispersible tablet. _Product imported from Poland:_ White to off-white, circular, freeze-dried tablets. 4 CLINICAL PARTICULARS As per PA0330/045/001 Product imported from Poland _contains glucose:_ This medicinal product contains glucose which is a component of maltodextrin contained in the composition mint flavour. Patients with glucose-galactose malabsorption should not take this medicinal product. 5 PHARMACOLOGICAL PROPERTIES As per PA0330/045/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Gelatin Mannitol (E421) Aspartame (E951) Sodium hydrogen carbonate Mint flavour 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Store in the original packaging. 6.5 NATURE AND CONTENTS OF CONTAINER Health Products Regulatory Authority 07 July 2023 CRN00DFR7 Page 2 of 2 PVC/OPA/Al/OPA/PVC foil blisters in a cardboard box. The pack contains 12 orodispersible tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER IMED Healthcare Ltd. Unit 625 Kilshane Avenue Northwest Business Park Ballycoolin Dublin 15 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1463/207/001 9 DATE OF FIRST AUTHORISATION/RENEWA Read the complete document